Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Privigen in Primary Immunodeficiency
NCT00168012Phase 3Completed
- Sponsor
- CSL Limited
- Start
- Sep 2004
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of intravenous immunoglobulin G in primary immunodeficiency disease (PID), sponsored by CSL Limited. Started Sep 2004; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
primary immunodeficiency disease (PID)
Beyond the preview
Go deeper on NCT00168012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00168012.